Search research articles
Contact Us
Filters
Showing results (51-60 of 109) with videos related to
Page
of 11
Sort By:
BMC Nephrology
|
May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
Pharmacoeconomics
|
February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK
Junwen Zhou, Runguo Wu, Claire Williams, et al.
Kidney International Reports
|
June 2, 2018
Impact of CKD on Household Income
Rachael L Morton, Iryna Schlackow, Alastair Gray, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model
Runguo Wu, Claire Williams, Junwen Zhou, et al.
NEJM Evidence
|
June 21, 2024
Effect of Fenofibrate on Progression of Diabetic Retinopathy
David Preiss, Jennifer Logue, Emily Sammons, et al.
International Journal of Epidemiology
|
November 30, 2017
Cohort Profile: The Korean Cancer Prevention Study-II (KCPS-II) Biobank
Yon Ho Jee, Jonathan Emberson, Keum Ji Jung, et al.
Lancet (London, England)
|
June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
, Colin Baigent, Lisa Blackwell, et al.
Kidney International
|
November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Benjamin C Storey, Natalie Staplin, Richard Haynes, et al.
Health Technology Assessment (Winchester, England)
|
December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The Lancet Regional Health. Europe
|
March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 109) with videos related to
Sort By:
Page
of 11
BMC Nephrology
|
May 1, 2015
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Seamus Kent, Iryna Schlackow, Jingky Lozano-Kühne, et al.
Pharmacoeconomics
|
February 24, 2023
Prediction Models for Individual-Level Healthcare Costs Associated with Cardiovascular Events in the UK
Junwen Zhou, Runguo Wu, Claire Williams, et al.
Kidney International Reports
|
June 2, 2018
Impact of CKD on Household Income
Rachael L Morton, Iryna Schlackow, Alastair Gray, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
February 19, 2024
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model
Runguo Wu, Claire Williams, Junwen Zhou, et al.
NEJM Evidence
|
June 21, 2024
Effect of Fenofibrate on Progression of Diabetic Retinopathy
David Preiss, Jennifer Logue, Emily Sammons, et al.
International Journal of Epidemiology
|
November 30, 2017
Cohort Profile: The Korean Cancer Prevention Study-II (KCPS-II) Biobank
Yon Ho Jee, Jonathan Emberson, Keum Ji Jung, et al.
Lancet (London, England)
|
June 2, 2009
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
, Colin Baigent, Lisa Blackwell, et al.
Kidney International
|
November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Benjamin C Storey, Natalie Staplin, Richard Haynes, et al.
Health Technology Assessment (Winchester, England)
|
December 7, 2024
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
The Lancet Regional Health. Europe
|
March 29, 2024
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study
Borislava Mihaylova, Runguo Wu, Junwen Zhou, et al.
Page
of 11